SAMDI Tech’s radioactivity assays overcome key challenges in drug discovery by offering key solutions, including:

• Detecting low amounts of product with sensitive assays
• Generating data rapidly with high-throughput, 384-well capabilities
• Characterising potent inhibitors by benefiting from lower enzyme concentrations

In this TechNote, learn how SAMDI Tech’s radioactivity assay characterised low turnover methyltransferase enzymes, highlighting:

• An assay format capable of measuring activities from picomolar enzyme concentrations
• Characterisation of kinetic parameters to develop assays suitable for compound characterisation
• An experienced team of biochemical experts with a collaborative approach
• A suite of label-free and beyond label-free technologies to generate high-quality data rapidly to advance drug discovery pipelines